Alison Smith

Alison Smith is a Scientist II at Kura Oncology, Inc. since August 2021, focusing on designing and executing in vitro and in vivo studies for therapeutic assessment of farnesyltransferase inhibitor combinations. Previously, Alison worked at Memorial Sloan Kettering Cancer Center as a Postdoctoral Research Fellow and PhD Candidate, where research identified recurrent MAPK pathway mutations in advanced HER2+ breast cancers. With expertise in molecular and cellular biology techniques, Alison contributed to various roles, including a summer student position at Pfizer assessing mitochondrial function in breast cancer, a research assistant at Colby College studying stress hormone signaling, and a summer undergraduate fellow at Rockefeller University. Alison holds a PhD in Cell Biology from Weill Cornell Graduate School of Medical Sciences and a BA in Cell and Molecular Biology/Biochemistry from Colby College.